NCM
BSX icon

Northside Capital Management’s Boston Scientific BSX Stock Holding History

Northside Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.84M Buy
160,366
+49,189
+44% +$2.67M 0.56% 54
2026
Q1 		$6.98M Buy
+111,177
New +$8.89M 0.61% 52

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Northside Capital Management's BSX Position: Q2 2026 in Review

Northside Capital Management increased its Boston Scientific (BSX) stake by 44% in Q2 2026, buying an estimated $2.67M and bringing the position to 160,366 shares worth $6.84M. The position accounts for 0.56% of the portfolio, ranked #54.

Northside Capital Management first reported a position in BSX in Q1 2026 and has held it in 2 quarters since. The position peaked at $6.98M in Q1 2026. 1,474 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Northside Capital Management held 160,366 shares of Boston Scientific worth $6.84M as of Q2 2026.
  • Northside Capital Management bought 49,189 Boston Scientific shares in Q2 2026, an estimated $2.67M.
  • Boston Scientific made up 0.56% of Northside Capital Management's portfolio in Q2 2026, its #54 holding.
  • Northside Capital Management first reported a position in Boston Scientific in Q1 2026 and has held it in 2 quarters since.
  • Northside Capital Management's Boston Scientific position peaked at $6.98M in Q1 2026.
  • 1,474 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Northside Capital Management's 13F filing for Q2 2026, filed 10 Jul 2026.